Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfic
|
ENSMUSG00000055053.11 | nuclear factor I/C |
Nfib
|
ENSMUSG00000008575.11 | nuclear factor I/B |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_82506741_82506912 | Nfib | 1047 | 0.413546 | 0.90 | 1.5e-02 | Click! |
chr4_82506362_82506636 | Nfib | 720 | 0.610981 | 0.87 | 2.4e-02 | Click! |
chr4_82471036_82471194 | Nfib | 28201 | 0.167333 | 0.87 | 2.4e-02 | Click! |
chr4_82497791_82497950 | Nfib | 1446 | 0.438762 | 0.87 | 2.5e-02 | Click! |
chr4_82476051_82476238 | Nfib | 23172 | 0.178696 | -0.86 | 2.9e-02 | Click! |
chr10_81402051_81402227 | Nfic | 1585 | 0.136916 | 0.93 | 7.0e-03 | Click! |
chr10_81430090_81430281 | Nfic | 820 | 0.331433 | 0.92 | 8.3e-03 | Click! |
chr10_81432990_81433152 | Nfic | 2066 | 0.120911 | 0.90 | 1.5e-02 | Click! |
chr10_81424901_81425064 | Nfic | 2132 | 0.113819 | 0.90 | 1.5e-02 | Click! |
chr10_81421860_81422025 | Nfic | 5172 | 0.068522 | 0.87 | 2.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_120643893_120644074 | 5.49 |
Gm42657 |
predicted gene 42657 |
2362 |
0.13 |
chr2_126520012_126520163 | 4.99 |
Atp8b4 |
ATPase, class I, type 8B, member 4 |
19413 |
0.19 |
chr3_104796399_104796698 | 4.95 |
Rhoc |
ras homolog family member C |
4565 |
0.1 |
chr14_18678485_18678659 | 4.71 |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
13422 |
0.25 |
chr11_64599304_64599471 | 4.22 |
Gm24275 |
predicted gene, 24275 |
8747 |
0.3 |
chr4_55047383_55047553 | 4.06 |
Zfp462 |
zinc finger protein 462 |
35988 |
0.17 |
chr10_5081367_5081706 | 3.97 |
Gm48836 |
predicted gene, 48836 |
9750 |
0.18 |
chr1_35927167_35927324 | 3.82 |
Gm8022 |
predicted gene 8022 |
31674 |
0.14 |
chr5_66232678_66232831 | 3.82 |
Gm3822 |
predicted gene 3822 |
18007 |
0.11 |
chr11_115803396_115803584 | 3.78 |
Caskin2 |
CASK-interacting protein 2 |
2609 |
0.14 |
chr1_35889876_35890029 | 3.74 |
1110002O04Rik |
RIKEN cDNA 1110002O04 gene |
10107 |
0.21 |
chr4_149978025_149978189 | 3.66 |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
23064 |
0.13 |
chr1_72830155_72830306 | 3.55 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
4908 |
0.25 |
chr14_37028669_37028833 | 3.54 |
Gm47885 |
predicted gene, 47885 |
4217 |
0.17 |
chr17_29496086_29496540 | 3.42 |
Pim1 |
proviral integration site 1 |
2906 |
0.15 |
chr17_24443544_24443715 | 3.41 |
Dnase1l2 |
deoxyribonuclease 1-like 2 |
524 |
0.46 |
chr6_28891682_28891856 | 3.39 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
11726 |
0.21 |
chr1_155063987_155064316 | 3.36 |
Gm29282 |
predicted gene 29282 |
6972 |
0.17 |
chr1_72854260_72854454 | 3.36 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
5658 |
0.23 |
chr15_89377019_89377232 | 3.35 |
Tymp |
thymidine phosphorylase |
86 |
0.89 |
chr2_93660090_93660241 | 3.31 |
Alx4 |
aristaless-like homeobox 4 |
17777 |
0.21 |
chr2_93126669_93126842 | 3.29 |
Gm13802 |
predicted gene 13802 |
28511 |
0.18 |
chr8_125926752_125926909 | 3.29 |
Map3k21 |
mitogen-activated protein kinase kinase kinase 21 |
16380 |
0.17 |
chr11_84440515_84440675 | 3.28 |
Aatf |
apoptosis antagonizing transcription factor |
8938 |
0.25 |
chr6_97521547_97521937 | 3.26 |
Gm25852 |
predicted gene, 25852 |
25825 |
0.16 |
chr17_27637268_27637552 | 3.24 |
Rps10 |
ribosomal protein S10 |
741 |
0.41 |
chr10_119010946_119011297 | 3.24 |
Gm47461 |
predicted gene, 47461 |
10549 |
0.17 |
chr1_87197456_87197613 | 3.22 |
Chrnd |
cholinergic receptor, nicotinic, delta polypeptide |
6690 |
0.1 |
chr7_25279091_25279275 | 3.22 |
Cic |
capicua transcriptional repressor |
458 |
0.64 |
chr4_124670340_124670505 | 3.19 |
Gm2164 |
predicted gene 2164 |
13253 |
0.09 |
chr2_30712077_30712436 | 3.16 |
Gm14488 |
predicted gene 14488 |
4787 |
0.16 |
chr7_141361641_141361795 | 3.14 |
Eps8l2 |
EPS8-like 2 |
181 |
0.86 |
chr8_125133982_125134146 | 3.13 |
Disc1 |
disrupted in schizophrenia 1 |
46077 |
0.14 |
chr7_80069741_80069903 | 3.13 |
Gm21057 |
predicted gene, 21057 |
5425 |
0.12 |
chr1_165486032_165486258 | 3.12 |
Adcy10 |
adenylate cyclase 10 |
934 |
0.38 |
chr1_72827972_72828123 | 3.10 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
2725 |
0.31 |
chr1_105885671_105885865 | 3.10 |
Gm37779 |
predicted gene, 37779 |
5244 |
0.21 |
chr18_20923338_20923520 | 3.01 |
Rnf125 |
ring finger protein 125 |
21196 |
0.18 |
chr3_88163993_88164144 | 3.01 |
Mef2d |
myocyte enhancer factor 2D |
1108 |
0.31 |
chr1_179061864_179062029 | 2.96 |
Smyd3 |
SET and MYND domain containing 3 |
72601 |
0.12 |
chr9_57831493_57831806 | 2.95 |
Arid3b |
AT rich interactive domain 3B (BRIGHT-like) |
2587 |
0.23 |
chr12_26364931_26365093 | 2.92 |
4930549C15Rik |
RIKEN cDNA 4930549C15 gene |
18295 |
0.16 |
chr1_72854483_72854969 | 2.91 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
6027 |
0.23 |
chr5_8157542_8157699 | 2.87 |
Gm21759 |
predicted gene, 21759 |
22016 |
0.16 |
chr3_37860164_37860325 | 2.85 |
Gm42753 |
predicted gene 42753 |
18446 |
0.14 |
chr3_97337526_97337699 | 2.84 |
Bcl9 |
B cell CLL/lymphoma 9 |
39695 |
0.14 |
chr5_120844838_120845004 | 2.83 |
Oas1f |
2'-5' oligoadenylate synthetase 1F |
2446 |
0.15 |
chr15_79741187_79741771 | 2.83 |
Sun2 |
Sad1 and UNC84 domain containing 2 |
613 |
0.45 |
chr5_115543763_115543979 | 2.82 |
Pxn |
paxillin |
76 |
0.94 |
chr3_145774471_145774622 | 2.81 |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
13798 |
0.2 |
chr11_50733265_50733435 | 2.81 |
Gm12200 |
predicted gene 12200 |
7806 |
0.16 |
chr11_75291668_75291835 | 2.80 |
Gm47300 |
predicted gene, 47300 |
26857 |
0.12 |
chr1_36603408_36603559 | 2.80 |
Gm6428 |
predicted pseudogene 6428 |
1681 |
0.22 |
chr15_74892121_74892301 | 2.80 |
Ly6m |
lymphocyte antigen 6 complex, locus M |
4810 |
0.11 |
chr8_10904045_10904209 | 2.77 |
Gm2814 |
predicted gene 2814 |
3569 |
0.12 |
chr9_25493952_25494135 | 2.76 |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
11176 |
0.2 |
chr8_46546530_46546687 | 2.76 |
Cenpu |
centromere protein U |
5420 |
0.17 |
chr6_141327276_141327440 | 2.75 |
Gm10400 |
predicted gene 10400 |
13195 |
0.24 |
chr3_18073803_18073954 | 2.73 |
Gm23726 |
predicted gene, 23726 |
4552 |
0.23 |
chr12_21227287_21227746 | 2.72 |
AC156032.1 |
|
19807 |
0.14 |
chr8_119444587_119444740 | 2.72 |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
2056 |
0.26 |
chr1_72851799_72851950 | 2.70 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
3175 |
0.28 |
chr1_36478308_36478497 | 2.68 |
Gm37909 |
predicted gene, 37909 |
4450 |
0.11 |
chr5_114435733_114435884 | 2.67 |
Mmab |
methylmalonic aciduria (cobalamin deficiency) cblB type homolog (human) |
8184 |
0.14 |
chr16_31419378_31420071 | 2.66 |
Bdh1 |
3-hydroxybutyrate dehydrogenase, type 1 |
2556 |
0.19 |
chr4_129126149_129126469 | 2.66 |
Hpca |
hippocalcin |
4273 |
0.13 |
chr1_39326083_39326234 | 2.66 |
Gm3617 |
predicted gene 3617 |
11259 |
0.15 |
chr5_88912785_88912944 | 2.65 |
Slc4a4 |
solute carrier family 4 (anion exchanger), member 4 |
21668 |
0.21 |
chr12_80598944_80599110 | 2.65 |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
924 |
0.35 |
chr12_86476167_86476343 | 2.62 |
Esrrb |
estrogen related receptor, beta |
6138 |
0.27 |
chr11_3132251_3132417 | 2.62 |
Pisd-ps1 |
phosphatidylserine decarboxylase, pseudogene 1 |
3362 |
0.16 |
chr10_5082148_5082330 | 2.61 |
Gm48836 |
predicted gene, 48836 |
9047 |
0.18 |
chr17_46018191_46018348 | 2.61 |
Vegfa |
vascular endothelial growth factor A |
3103 |
0.22 |
chr10_122408778_122408952 | 2.60 |
Gm36041 |
predicted gene, 36041 |
21973 |
0.18 |
chr3_88149158_88149546 | 2.60 |
Mef2d |
myocyte enhancer factor 2D |
6778 |
0.11 |
chr1_135644213_135644364 | 2.58 |
Nav1 |
neuron navigator 1 |
43817 |
0.12 |
chr3_107931566_107932141 | 2.57 |
Gstm7 |
glutathione S-transferase, mu 7 |
36 |
0.93 |
chr12_82932725_82932921 | 2.57 |
1700085C21Rik |
RIKEN cDNA 1700085C21 gene |
6332 |
0.24 |
chr1_88259328_88259499 | 2.56 |
Mroh2a |
maestro heat-like repeat family member 2A |
1655 |
0.22 |
chr8_120832109_120832260 | 2.53 |
Gm26878 |
predicted gene, 26878 |
48022 |
0.12 |
chr17_28287629_28287780 | 2.52 |
Ppard |
peroxisome proliferator activator receptor delta |
5542 |
0.12 |
chr17_28280110_28280287 | 2.52 |
Ppard |
peroxisome proliferator activator receptor delta |
8079 |
0.11 |
chr18_75999924_76000088 | 2.51 |
1700003O11Rik |
RIKEN cDNA 1700003O11 gene |
15671 |
0.23 |
chr12_109510510_109510682 | 2.51 |
Gm34081 |
predicted gene, 34081 |
6144 |
0.06 |
chr2_104103337_104103528 | 2.51 |
Cd59a |
CD59a antigen |
7592 |
0.12 |
chr6_126034904_126035055 | 2.49 |
Ntf3 |
neurotrophin 3 |
129981 |
0.05 |
chr5_118294104_118294293 | 2.48 |
Gm25076 |
predicted gene, 25076 |
27749 |
0.15 |
chr6_72601356_72601528 | 2.47 |
Retsat |
retinol saturase (all trans retinol 13,14 reductase) |
2814 |
0.11 |
chr6_29535400_29535569 | 2.47 |
Irf5 |
interferon regulatory factor 5 |
4236 |
0.13 |
chr5_74975179_74975330 | 2.46 |
Gm42577 |
predicted gene 42577 |
13812 |
0.15 |
chr11_67536573_67536724 | 2.46 |
Gas7 |
growth arrest specific 7 |
10506 |
0.23 |
chr6_99991198_99991358 | 2.45 |
Gm33201 |
predicted gene, 33201 |
63 |
0.98 |
chr1_89104297_89104643 | 2.45 |
Gm38312 |
predicted gene, 38312 |
7397 |
0.21 |
chr19_4050053_4050204 | 2.43 |
Gstp2 |
glutathione S-transferase, pi 2 |
4105 |
0.07 |
chr9_45122305_45122459 | 2.43 |
Scn2b |
sodium channel, voltage-gated, type II, beta |
4501 |
0.1 |
chr14_101652712_101652891 | 2.42 |
Uchl3 |
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) |
1166 |
0.44 |
chr16_30553048_30553230 | 2.41 |
Tmem44 |
transmembrane protein 44 |
2297 |
0.3 |
chrX_7739419_7739581 | 2.41 |
Ccdc120 |
coiled-coil domain containing 120 |
707 |
0.42 |
chr10_87639840_87639991 | 2.40 |
Gm48195 |
predicted gene, 48195 |
48663 |
0.15 |
chr8_126809278_126809587 | 2.40 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
29801 |
0.17 |
chr4_155280571_155280741 | 2.40 |
Prkcz |
protein kinase C, zeta |
7614 |
0.17 |
chr15_101987064_101987215 | 2.39 |
Gm36026 |
predicted gene, 36026 |
17073 |
0.1 |
chr12_8337329_8337507 | 2.38 |
Gm48071 |
predicted gene, 48071 |
701 |
0.63 |
chr13_75931245_75931396 | 2.37 |
Gm15528 |
predicted gene 15528 |
992 |
0.41 |
chr17_27636792_27636990 | 2.37 |
Rps10 |
ribosomal protein S10 |
222 |
0.82 |
chr4_138440154_138440340 | 2.37 |
Mul1 |
mitochondrial ubiquitin ligase activator of NFKB 1 |
5524 |
0.14 |
chr17_46162734_46163102 | 2.36 |
Gtpbp2 |
GTP binding protein 2 |
115 |
0.93 |
chr8_71312491_71313043 | 2.35 |
Myo9b |
myosin IXb |
21050 |
0.11 |
chr5_28798391_28798542 | 2.34 |
Gm43161 |
predicted gene 43161 |
221193 |
0.02 |
chr8_10873138_10873312 | 2.34 |
Gm32540 |
predicted gene, 32540 |
7039 |
0.11 |
chr1_64308159_64308318 | 2.34 |
Gm28981 |
predicted gene 28981 |
5195 |
0.28 |
chr5_66200133_66200302 | 2.34 |
Gm15794 |
predicted gene 15794 |
1109 |
0.34 |
chr18_43360044_43360530 | 2.34 |
Dpysl3 |
dihydropyrimidinase-like 3 |
12936 |
0.23 |
chr6_125515545_125515708 | 2.33 |
Cd9 |
CD9 antigen |
20835 |
0.13 |
chr18_52749971_52750153 | 2.32 |
Sncaip |
synuclein, alpha interacting protein (synphilin) |
17647 |
0.21 |
chr3_153943357_153943702 | 2.31 |
Acadm |
acyl-Coenzyme A dehydrogenase, medium chain |
913 |
0.42 |
chrX_143068243_143068408 | 2.31 |
Rtl9 |
retrotransposon Gag like 9 |
31269 |
0.21 |
chr15_84973321_84973490 | 2.31 |
5031439G07Rik |
RIKEN cDNA 5031439G07 gene |
12422 |
0.11 |
chr1_170555009_170555214 | 2.30 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
1999 |
0.38 |
chrX_12089752_12089915 | 2.29 |
Bcor |
BCL6 interacting corepressor |
9280 |
0.27 |
chr15_61942367_61942518 | 2.29 |
Gm37947 |
predicted gene, 37947 |
40860 |
0.16 |
chr17_27779235_27779414 | 2.28 |
Rps2-ps9 |
ribosomal protein S2, pseudogene 9 |
5055 |
0.14 |
chr10_108979737_108980117 | 2.28 |
Gm47477 |
predicted gene, 47477 |
23439 |
0.22 |
chr7_19933327_19933498 | 2.28 |
Igsf23 |
immunoglobulin superfamily, member 23 |
11486 |
0.07 |
chr11_88849470_88849637 | 2.28 |
Akap1 |
A kinase (PRKA) anchor protein 1 |
1950 |
0.25 |
chr11_98750923_98751087 | 2.28 |
Thra |
thyroid hormone receptor alpha |
2581 |
0.15 |
chr10_5080930_5081103 | 2.27 |
Gm48836 |
predicted gene, 48836 |
10270 |
0.17 |
chr10_5082451_5082641 | 2.27 |
Gm48836 |
predicted gene, 48836 |
8740 |
0.18 |
chr8_71572922_71573096 | 2.27 |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
2354 |
0.12 |
chr4_118402815_118402985 | 2.26 |
Szt2 |
SZT2 subunit of KICSTOR complex |
6373 |
0.12 |
chr6_22280576_22280754 | 2.26 |
Wnt16 |
wingless-type MMTV integration site family, member 16 |
7562 |
0.23 |
chr5_91641118_91641280 | 2.26 |
Trmt112-ps1 |
tRNA methyltransferase 11-2, pseudogene 1 |
96880 |
0.06 |
chr2_101819016_101819167 | 2.26 |
Prr5l |
proline rich 5 like |
4758 |
0.26 |
chr9_64771236_64771418 | 2.26 |
Rab11a |
RAB11A, member RAS oncogene family |
33569 |
0.14 |
chr15_97789754_97789926 | 2.25 |
Hdac7 |
histone deacetylase 7 |
4605 |
0.14 |
chr2_34146537_34146688 | 2.24 |
Gm38389 |
predicted gene, 38389 |
35168 |
0.17 |
chr1_89108718_89108882 | 2.24 |
Gm38312 |
predicted gene, 38312 |
11727 |
0.2 |
chr9_50874153_50874482 | 2.23 |
Ppp2r1b |
protein phosphatase 2, regulatory subunit A, beta |
1305 |
0.4 |
chr9_105880827_105880978 | 2.22 |
Col6a5 |
collagen, type VI, alpha 5 |
904 |
0.62 |
chr3_85842921_85843092 | 2.22 |
Fam160a1 |
family with sequence similarity 160, member A1 |
25715 |
0.12 |
chr17_35485809_35485978 | 2.22 |
H2-Q10 |
histocompatibility 2, Q region locus 10 |
15796 |
0.07 |
chr11_97531489_97531677 | 2.21 |
Srcin1 |
SRC kinase signaling inhibitor 1 |
5362 |
0.14 |
chr8_10953718_10953890 | 2.21 |
Gm44955 |
predicted gene 44955 |
5914 |
0.12 |
chr13_38089569_38089757 | 2.21 |
Gm27387 |
predicted gene, 27387 |
3461 |
0.21 |
chr14_99616632_99616869 | 2.20 |
Gm49225 |
predicted gene, 49225 |
3266 |
0.27 |
chr11_94475826_94475993 | 2.19 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
1711 |
0.26 |
chr4_132129267_132129447 | 2.18 |
Oprd1 |
opioid receptor, delta 1 |
15129 |
0.1 |
chrX_108621044_108621195 | 2.18 |
Gm379 |
predicted gene 379 |
43336 |
0.19 |
chr10_93736289_93736487 | 2.18 |
Gm15963 |
predicted gene 15963 |
8181 |
0.16 |
chr18_32385962_32386113 | 2.17 |
A830052D11Rik |
RIKEN cDNA A830052D11 gene |
7759 |
0.19 |
chr2_162975309_162975478 | 2.17 |
Gm11453 |
predicted gene 11453 |
7868 |
0.13 |
chr10_80963823_80963984 | 2.17 |
Gm3828 |
predicted gene 3828 |
9193 |
0.1 |
chr13_59509852_59510003 | 2.17 |
Agtpbp1 |
ATP/GTP binding protein 1 |
4227 |
0.2 |
chr4_86686025_86686176 | 2.16 |
Plin2 |
perilipin 2 |
16040 |
0.18 |
chr18_4980453_4980617 | 2.16 |
Svil |
supervillin |
13278 |
0.29 |
chr1_78650012_78650396 | 2.14 |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
7621 |
0.17 |
chr14_20318204_20318418 | 2.14 |
Nudt13 |
nudix (nucleoside diphosphate linked moiety X)-type motif 13 |
6882 |
0.13 |
chrX_38711507_38711658 | 2.14 |
Ap3s1-ps1 |
adaptor-related protein complex 3, sigma 1 subunit, pseudogene 1 |
25412 |
0.13 |
chr11_44172606_44172757 | 2.14 |
Gm12154 |
predicted gene 12154 |
94528 |
0.08 |
chr8_22521190_22521341 | 2.13 |
Slc20a2 |
solute carrier family 20, member 2 |
15039 |
0.14 |
chr14_63150536_63150699 | 2.13 |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
14308 |
0.13 |
chr19_4616707_4616858 | 2.12 |
Lrfn4 |
leucine rich repeat and fibronectin type III domain containing 4 |
1115 |
0.34 |
chr5_121859857_121860008 | 2.12 |
Cux2 |
cut-like homeobox 2 |
6131 |
0.12 |
chr3_57288431_57288618 | 2.11 |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
5179 |
0.21 |
chr9_67025413_67025580 | 2.11 |
Tpm1 |
tropomyosin 1, alpha |
7329 |
0.18 |
chr10_20241060_20241211 | 2.11 |
Map7 |
microtubule-associated protein 7 |
11340 |
0.14 |
chr3_144760784_144760953 | 2.10 |
Clca3a1 |
chloride channel accessory 3A1 |
27 |
0.96 |
chr17_14167715_14167878 | 2.10 |
Gm34510 |
predicted gene, 34510 |
35932 |
0.12 |
chr8_84921680_84921849 | 2.10 |
Mast1 |
microtubule associated serine/threonine kinase 1 |
2350 |
0.1 |
chr6_138141390_138141696 | 2.10 |
Mgst1 |
microsomal glutathione S-transferase 1 |
43 |
0.99 |
chr4_144981227_144981590 | 2.09 |
Vps13d |
vacuolar protein sorting 13D |
2553 |
0.3 |
chr6_29117593_29117759 | 2.09 |
Gm25589 |
predicted gene, 25589 |
4070 |
0.17 |
chr10_60262496_60262672 | 2.09 |
Psap |
prosaposin |
15043 |
0.17 |
chr11_120262471_120262637 | 2.09 |
Gm47297 |
predicted gene, 47297 |
11933 |
0.1 |
chr8_126837360_126837521 | 2.09 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
1793 |
0.38 |
chr7_135609772_135609956 | 2.08 |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
4036 |
0.22 |
chr15_75596455_75596620 | 2.08 |
Gpihbp1 |
GPI-anchored HDL-binding protein 1 |
91 |
0.95 |
chr5_35719956_35720115 | 2.07 |
Sh3tc1 |
SH3 domain and tetratricopeptide repeats 1 |
797 |
0.57 |
chr7_70624108_70624295 | 2.06 |
Gm44808 |
predicted gene 44808 |
14409 |
0.16 |
chr11_100896167_100896318 | 2.06 |
Stat3 |
signal transducer and activator of transcription 3 |
1120 |
0.41 |
chr8_10946099_10946520 | 2.06 |
Gm44955 |
predicted gene 44955 |
1581 |
0.25 |
chr1_72795562_72795734 | 2.06 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
28855 |
0.17 |
chr7_99474130_99474281 | 2.05 |
Klhl35 |
kelch-like 35 |
2379 |
0.16 |
chr2_25429840_25429995 | 2.04 |
Abca2 |
ATP-binding cassette, sub-family A (ABC1), member 2 |
1214 |
0.22 |
chr4_130181948_130182117 | 2.04 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
6910 |
0.17 |
chr11_109505108_109505274 | 2.03 |
Gm22378 |
predicted gene, 22378 |
5367 |
0.15 |
chr10_5082743_5082927 | 2.03 |
Gm48836 |
predicted gene, 48836 |
8451 |
0.18 |
chr1_72832955_72833106 | 2.02 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
7708 |
0.23 |
chr16_91916614_91917006 | 2.02 |
Gm25245 |
predicted gene, 25245 |
4605 |
0.12 |
chr7_142622273_142622480 | 2.01 |
Gm33148 |
predicted gene, 33148 |
30632 |
0.08 |
chr19_46142576_46142826 | 2.00 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
1718 |
0.25 |
chr9_96977704_96977870 | 2.00 |
Spsb4 |
splA/ryanodine receptor domain and SOCS box containing 4 |
5812 |
0.18 |
chr10_44474418_44474575 | 2.00 |
Prdm1 |
PR domain containing 1, with ZNF domain |
15748 |
0.18 |
chr15_100619273_100619433 | 2.00 |
Dazap2 |
DAZ associated protein 2 |
3021 |
0.11 |
chr4_33266355_33266510 | 2.00 |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
17922 |
0.15 |
chr8_8959238_8959490 | 2.00 |
Gm44515 |
predicted gene 44515 |
26665 |
0.21 |
chr11_49986763_49986926 | 2.00 |
Rasgef1c |
RasGEF domain family, member 1C |
23059 |
0.15 |
chr8_70565783_70565942 | 1.99 |
Ell |
elongation factor RNA polymerase II |
26174 |
0.07 |
chr10_82220492_82220673 | 1.99 |
Zfp938 |
zinc finger protein 938 |
20691 |
0.13 |
chr15_67343383_67343547 | 1.99 |
1700012I11Rik |
RIKEN cDNA 1700012I11 gene |
116696 |
0.06 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.0 | 3.9 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.0 | 2.9 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.9 | 2.8 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.9 | 4.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.9 | 3.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.8 | 2.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.8 | 2.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.8 | 2.4 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.8 | 2.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.8 | 2.4 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.8 | 2.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.8 | 3.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.8 | 2.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.7 | 2.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.7 | 1.4 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.7 | 0.7 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.6 | 6.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.6 | 2.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.6 | 1.8 | GO:0003032 | detection of oxygen(GO:0003032) |
0.6 | 1.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.6 | 1.7 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.6 | 1.7 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.6 | 1.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.6 | 1.7 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 2.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 2.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.5 | 2.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.5 | 1.1 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.5 | 2.2 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.5 | 2.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.5 | 1.6 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.5 | 2.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.5 | 1.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 1.6 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.5 | 2.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.5 | 1.5 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.5 | 2.4 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.5 | 1.5 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 2.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.5 | 4.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.5 | 1.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 3.3 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.5 | 1.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.5 | 1.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 2.3 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.5 | 1.4 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.5 | 1.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.5 | 1.8 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.5 | 0.5 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.5 | 1.4 | GO:0008050 | female courtship behavior(GO:0008050) |
0.4 | 1.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 1.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.4 | 1.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 1.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 2.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 0.4 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.4 | 1.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 0.4 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 1.7 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.4 | 2.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 2.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 1.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.4 | 0.8 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.4 | 1.2 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 1.6 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.4 | 1.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 1.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.4 | 1.6 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 1.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 8.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 1.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 1.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 2.3 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.4 | 1.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.4 | 0.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.4 | 1.1 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.4 | 1.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.4 | 1.5 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.4 | 1.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 1.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 0.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.4 | 1.5 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 0.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.4 | 2.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.4 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 1.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.4 | 1.1 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.4 | 1.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 1.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.4 | 1.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 3.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 0.3 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 0.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 1.0 | GO:0003166 | bundle of His development(GO:0003166) |
0.3 | 1.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 1.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 1.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 1.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 1.6 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.3 | 0.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 2.2 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.3 | 1.0 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 1.0 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.3 | 3.8 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.3 | 2.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 1.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.6 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.9 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 0.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.3 | 2.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 1.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 0.6 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.3 | 0.9 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 1.2 | GO:0006848 | pyruvate transport(GO:0006848) |
0.3 | 0.9 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 1.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.3 | 1.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 0.9 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 0.9 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.3 | 0.3 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.3 | 0.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 0.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 2.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 | 0.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 1.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 0.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 1.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 2.5 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.3 | 0.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 0.8 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.3 | 0.3 | GO:1903055 | positive regulation of extracellular matrix organization(GO:1903055) |
0.3 | 1.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 0.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 2.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.5 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.3 | 3.2 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.3 | 0.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 0.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 1.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 0.5 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 1.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 0.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 0.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 1.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 0.8 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 0.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 2.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 3.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 1.0 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 0.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 4.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 1.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.7 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.2 | 0.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 1.9 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.7 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 1.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.7 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.5 | GO:0045472 | response to ether(GO:0045472) |
0.2 | 1.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 0.5 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 0.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.2 | 0.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 2.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.9 | GO:0009750 | response to fructose(GO:0009750) |
0.2 | 1.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 1.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 1.6 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 | 1.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.2 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.2 | 2.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.2 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.2 | 0.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 0.7 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.2 | 1.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.7 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 2.4 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.7 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 0.9 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.9 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 0.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.7 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 2.0 | GO:0048241 | epinephrine transport(GO:0048241) |
0.2 | 1.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.4 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 1.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 0.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 1.3 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 1.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.4 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 1.5 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.2 | 0.6 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.9 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.2 | 2.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 1.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.2 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 0.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 1.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 1.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 0.6 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.2 | 0.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.4 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.2 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.2 | GO:0051794 | regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) |
0.2 | 1.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.6 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.4 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.2 | 1.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.4 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 0.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 1.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 2.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 1.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.2 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 3.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 1.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 1.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.4 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 1.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 0.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 0.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 2.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.8 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.2 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.2 | 0.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 0.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 0.4 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 1.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.4 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.2 | 0.2 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.2 | 1.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.2 | 0.2 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.2 | 1.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 1.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.2 | 0.9 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 1.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.2 | GO:0043217 | myelin maintenance(GO:0043217) |
0.2 | 0.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 2.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.2 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.2 | 0.6 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.2 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.2 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.2 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 1.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 0.4 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 1.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.5 | GO:0015677 | copper ion import(GO:0015677) |
0.2 | 0.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 0.7 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.2 | GO:0035855 | megakaryocyte differentiation(GO:0030219) megakaryocyte development(GO:0035855) |
0.2 | 0.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.2 | 0.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.2 | 1.7 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.2 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.9 | GO:0060022 | hard palate development(GO:0060022) |
0.2 | 0.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 0.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 1.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.7 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 0.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 1.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.5 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.2 | GO:0051204 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.2 | 0.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 0.7 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 1.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 1.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.5 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.2 | 0.5 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 0.5 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.2 | 0.7 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 0.8 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 0.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.2 | 1.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 2.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.2 | 0.6 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.2 | 1.6 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.6 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.2 | 0.9 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.6 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.2 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 1.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 1.4 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.6 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 0.3 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.2 | 0.5 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.2 | 0.2 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.2 | 0.6 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.2 | GO:0043485 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.2 | 0.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 1.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.2 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.2 | 0.6 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.2 | 1.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 1.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 0.6 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.2 | 0.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 2.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.3 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.2 | 2.4 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.1 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.1 | 1.6 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 1.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.9 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.4 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 2.0 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.4 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.1 | 1.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.7 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.9 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 1.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.3 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 1.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 1.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 3.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.6 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 1.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 2.7 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.3 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 1.3 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.3 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.1 | 3.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.7 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.3 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.3 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 1.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.5 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.4 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) small RNA loading onto RISC(GO:0070922) |
0.1 | 2.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.4 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.1 | 0.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.9 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.7 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.4 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.5 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.3 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.3 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.1 | 0.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 1.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.3 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 0.1 | GO:0045632 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.1 | 0.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 1.4 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.4 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.1 | 0.6 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.5 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.6 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.2 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 1.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 1.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.6 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.9 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 1.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.7 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.1 | 0.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 1.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.9 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.6 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.4 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.1 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 1.5 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.4 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 1.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 2.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 7.4 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.1 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.7 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.5 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.9 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.1 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.5 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.5 | GO:0061140 | Type II pneumocyte differentiation(GO:0060510) lung secretory cell differentiation(GO:0061140) |
0.1 | 1.0 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.8 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 1.4 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.1 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.3 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 0.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 1.0 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 2.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.2 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.1 | 0.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 1.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 2.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 1.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 1.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.3 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 1.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.8 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.1 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 2.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 1.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 1.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.7 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.8 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 1.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 1.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 2.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.2 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 1.2 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.1 | 0.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.7 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.7 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 1.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.2 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.3 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.1 | 0.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.5 | GO:0002420 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.2 | GO:0090189 | regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.1 | 0.3 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.6 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.2 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.1 | 1.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.3 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 3.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 3.1 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 1.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 1.2 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.1 | 1.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.8 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 1.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.9 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.3 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.6 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 3.3 | GO:0006821 | chloride transport(GO:0006821) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.5 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.1 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.4 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.1 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 1.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 1.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.3 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.4 | GO:1990089 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.3 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 1.3 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.1 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.3 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.2 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.1 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.1 | 0.2 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.1 | 0.2 | GO:0001794 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.8 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.4 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.2 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.7 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.1 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.4 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 1.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 2.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.1 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
0.1 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 1.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 5.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 1.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.2 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.2 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.1 | 0.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.2 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.8 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.1 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 2.8 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 1.3 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.3 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.8 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 1.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.1 | 0.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.9 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 0.6 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.1 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.4 | GO:0090083 | inclusion body assembly(GO:0070841) regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.4 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.1 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 1.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.2 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.1 | 0.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.3 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 1.3 | GO:0030431 | sleep(GO:0030431) |
0.1 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 2.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 1.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.4 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 1.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 1.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.1 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.4 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.1 | 0.1 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.1 | 0.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.6 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.1 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.3 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.1 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.7 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 0.3 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.1 | 0.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.2 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.6 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.3 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.1 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.1 | 0.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.1 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.1 | 0.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.8 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.4 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.1 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.7 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 0.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.2 | GO:0051893 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
0.1 | 3.7 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.1 | 0.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.9 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 1.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.4 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.1 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 1.4 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.1 | 1.1 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.1 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.5 | GO:0014044 | Schwann cell development(GO:0014044) |
0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 1.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.5 | GO:0006956 | complement activation(GO:0006956) |
0.1 | 0.1 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.1 | 0.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 1.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.8 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.1 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) mitochondrial protein processing(GO:0034982) |
0.1 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.1 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.3 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.1 | 1.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.2 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.3 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.4 | GO:0071548 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.1 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.1 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.1 | 0.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.2 | GO:0042772 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.1 | 1.7 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.1 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.1 | 0.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.5 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.1 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.1 | 0.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.1 | 1.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 0.1 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.1 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.1 | 0.2 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.1 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.2 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.1 | 0.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 0.5 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 0.6 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 1.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.1 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 0.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.1 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.2 | GO:0072574 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.3 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.0 | GO:0048670 | regulation of collateral sprouting(GO:0048670) positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.4 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.1 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.0 | 0.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 1.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.4 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.6 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.0 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.0 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.1 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.5 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.7 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.2 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.2 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.0 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.3 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.0 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.0 | 0.4 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.7 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 1.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 2.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.1 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.4 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
0.0 | 0.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.0 | 0.0 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.4 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.5 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.0 | GO:0006901 | vesicle coating(GO:0006901) |
0.0 | 0.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.1 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.1 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.2 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.6 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0072529 | pyrimidine-containing compound catabolic process(GO:0072529) |
0.0 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.3 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.0 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.5 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.0 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.2 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.0 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.0 | 0.0 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.4 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.0 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.0 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.0 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.3 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.4 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.3 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.2 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.0 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.0 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
0.0 | 0.2 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.2 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.0 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.1 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.1 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.0 | 0.0 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.0 | 0.0 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.1 | GO:0021544 | subpallium development(GO:0021544) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.0 | GO:0071371 | response to gonadotropin(GO:0034698) cellular response to gonadotropin stimulus(GO:0071371) |
0.0 | 1.0 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
0.0 | 0.0 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.0 | 1.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.0 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.1 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.1 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.0 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.0 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.0 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.2 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.0 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.2 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.0 | 0.3 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0045078 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.0 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.0 | 0.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.0 | 0.4 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
0.0 | 0.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.3 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.0 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.2 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.6 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.7 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.2 | GO:0097369 | sodium ion import(GO:0097369) |
0.0 | 0.0 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) |
0.0 | 0.0 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.0 | 0.2 | GO:0009069 | serine family amino acid metabolic process(GO:0009069) |
0.0 | 0.1 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.5 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:0072608 | interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) |
0.0 | 0.1 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.7 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.0 | 0.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.0 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.0 | 0.0 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.0 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.0 | 0.1 | GO:0051292 | pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
0.0 | 0.0 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 1.4 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.0 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.0 | 0.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.0 | 0.2 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.3 | GO:0001841 | neural tube formation(GO:0001841) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 1.4 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.3 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.0 | 0.3 | GO:0050905 | neuromuscular process(GO:0050905) |
0.0 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.1 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 1.2 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.9 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.0 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.3 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.3 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.0 | 0.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.0 | 0.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.8 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.0 | 0.8 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.0 | 0.1 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.0 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.0 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.0 | 0.0 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.0 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.0 | 0.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.0 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.0 | 0.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 0.2 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.0 | GO:0090175 | regulation of establishment of planar polarity(GO:0090175) |
0.0 | 1.8 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.0 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.5 | GO:0016197 | endosomal transport(GO:0016197) |
0.0 | 0.0 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 7.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.9 | 0.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 0.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.7 | 2.2 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.6 | 0.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.6 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 1.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 1.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 1.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 3.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 1.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 2.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.4 | 1.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 1.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 1.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 2.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 1.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 0.3 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 6.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 0.9 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 0.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 0.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 1.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 5.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 0.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.3 | 1.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 0.8 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 1.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 1.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 4.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 2.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 0.9 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 0.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 1.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 0.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.2 | 1.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 1.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 1.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 1.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 5.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.4 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 5.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 1.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 1.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 2.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.7 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 2.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 1.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.7 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 1.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 9.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 4.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 4.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 0.2 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 1.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 0.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 3.9 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 1.1 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 0.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.9 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.9 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 1.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.3 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.9 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 2.0 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 4.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 5.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 1.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 2.8 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.1 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 2.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 2.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.8 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.9 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 11.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 1.9 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.4 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.1 | 0.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 4.1 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.5 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.4 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.1 | 0.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.6 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 1.2 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 0.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 1.4 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 1.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 1.3 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 1.1 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 5.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 3.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 4.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.3 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 0.3 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 4.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.7 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 2.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 1.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 4.4 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 4.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 3.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.7 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 1.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.6 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 5.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 1.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 3.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 2.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.1 | GO:0005818 | aster(GO:0005818) |
0.1 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 2.0 | GO:0031256 | leading edge membrane(GO:0031256) |
0.1 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.4 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 5.7 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 1.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 1.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 2.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.8 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.6 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.6 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 1.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.8 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.2 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 2.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 3.1 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 0.1 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.1 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 2.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.1 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 2.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 1.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 1.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.5 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 1.7 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.1 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.9 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 0.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 5.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 2.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.2 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 2.7 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 1.0 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.5 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 46.9 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 2.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.6 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 13.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.0 | GO:0012505 | endomembrane system(GO:0012505) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 2.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 3.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 2.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 1.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.9 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 1.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 1.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 2.1 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.6 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 4.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 1.3 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.3 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 1.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.8 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 2.9 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 1.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 1.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.7 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 1.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 8.9 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 2.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.3 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.3 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 4.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 1.6 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 1.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 2.0 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 1.5 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 25.0 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.1 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 1.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.3 | GO:0032991 | macromolecular complex(GO:0032991) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 2.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.7 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.2 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 2.9 | GO:0097708 | cytoplasmic vesicle(GO:0031410) intracellular vesicle(GO:0097708) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 4.0 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 18.2 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.5 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 0.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 1.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 8.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 3.4 | GO:0016020 | membrane(GO:0016020) |
0.0 | 0.2 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.0 | 0.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 4.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 23.5 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 43.4 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 73.5 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 11.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.3 | 4.0 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.8 | 2.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.7 | 2.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.7 | 2.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 7.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 1.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.6 | 2.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 2.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.6 | 3.5 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 1.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 1.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 1.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.5 | 8.0 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 3.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 1.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 2.5 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.5 | 1.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.5 | 2.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 1.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 0.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 0.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.4 | 2.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 2.2 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 4.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 1.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 2.9 | GO:0018644 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.4 | 0.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.4 | 2.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.4 | 1.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 1.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.4 | 1.6 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 1.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 1.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 2.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 6.0 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 1.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.4 | 1.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 1.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 1.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 4.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 1.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 1.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 1.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.4 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 0.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.4 | 1.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.4 | 2.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 2.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.3 | 2.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.7 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 0.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.3 | 1.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 0.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.3 | 0.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 2.8 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 1.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 1.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 1.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 0.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 3.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 0.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 0.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 0.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 1.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 2.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 2.8 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.3 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 1.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 2.6 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.3 | 0.8 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 3.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 2.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 1.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 4.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 3.0 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 2.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 1.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.7 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 2.8 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.9 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 1.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 1.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 1.3 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.7 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 0.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 0.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 3.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 0.7 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 4.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 0.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 2.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 0.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 3.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 5.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 2.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 5.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 1.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 0.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 1.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 0.2 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.2 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 1.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 1.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 3.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 6.2 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
0.2 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.4 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 0.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 0.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 2.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 1.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 1.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 1.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 0.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 1.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.9 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.2 | 0.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 0.7 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.8 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 0.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 4.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 1.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 3.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 1.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 0.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 1.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 1.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.3 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 1.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 1.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 2.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.4 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 1.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.1 | 1.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.7 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.5 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.5 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.8 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 2.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 1.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 6.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.6 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 1.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 3.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.5 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 0.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 2.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 1.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 1.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.6 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 5.0 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 1.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 1.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 1.1 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 3.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 1.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 1.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.5 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 1.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.8 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 1.7 | GO:0019198 | transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 1.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.8 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 1.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 1.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.3 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 4.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 1.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 5.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.8 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 0.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 4.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 1.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 6.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 1.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.3 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.7 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.1 | 0.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 2.8 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 0.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.3 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.1 | 0.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 2.7 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 1.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 1.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 1.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 2.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 0.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.3 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 2.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.2 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 4.3 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 1.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 22.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 2.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.6 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.8 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 0.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 2.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.8 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.3 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.1 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 1.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.7 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 3.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 1.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.2 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 1.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 10.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 2.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.8 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 1.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 1.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 1.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 1.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 1.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.1 | GO:0032557 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.5 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.5 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 1.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 2.0 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 1.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 1.0 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.1 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.0 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 1.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.5 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.8 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.3 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.0 | 0.7 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 2.7 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
0.0 | 1.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 7.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 1.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.3 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 2.5 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 1.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 2.8 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.0 | 0.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.5 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.2 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.7 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.0 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.3 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 2.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.0 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0005501 | retinoid binding(GO:0005501) |
0.0 | 0.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.1 | GO:0019840 | isoprenoid binding(GO:0019840) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 7.1 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 2.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.6 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.2 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.7 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.0 | 0.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 1.2 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 2.6 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.8 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 1.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 1.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 2.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.4 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.7 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 1.2 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.5 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.6 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.0 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.6 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 10.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 1.2 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 7.0 | GO:0001067 | regulatory region nucleic acid binding(GO:0001067) |
0.0 | 0.8 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 5.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.0 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.0 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.0 | 0.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.0 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 1.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.4 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 0.2 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.0 | 0.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.1 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.0 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.9 | GO:0005125 | cytokine activity(GO:0005125) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 6.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 5.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 1.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 4.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 3.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 6.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 3.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 2.3 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 6.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 3.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 1.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 3.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 6.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 1.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 4.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 2.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 2.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 0.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 0.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 7.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 5.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 18.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 3.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 2.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 3.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 2.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 2.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 6.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 3.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 2.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.5 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 7.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 8.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 1.2 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 10.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.6 | 4.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 1.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 5.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 2.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 5.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 3.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 2.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 4.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 2.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 1.6 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.2 | 3.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 6.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 5.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 5.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 2.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 4.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 3.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 1.7 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 3.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 1.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 0.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.2 | 1.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 4.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 1.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 2.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 1.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 1.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 2.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 1.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 1.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 1.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 3.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 2.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 1.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 6.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 3.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 2.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.4 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 10.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.7 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 1.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.6 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 1.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.7 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 2.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 2.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.6 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 1.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.5 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 1.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 3.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 1.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 3.8 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 4.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 1.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 2.7 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 1.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 6.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 3.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 5.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.8 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 2.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.1 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.0 | 1.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.5 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 1.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.8 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 3.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 1.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 3.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.6 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.0 | 0.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.5 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |